Application of rivaroxaban in patients with non-valvular atrial fibrillation and end-stage kidney disease: A systematic review and meta-analysis

BACKGROUND: Nowadays, the number of patients with non-valvular atrial fibrillation (NVAF) complicated by end-stage renal disease (ESKD) is increasing. There are significant challenges in anticoagulation with prescription drugs because of the high risk of bleeding and embolism among these patients. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Zhenzhen, Wang, Jieya, Yuan, Ye, Cheng, Tian, Ren, Feifei, Wang, Songsong, Zhang, Zhiqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951003/
https://www.ncbi.nlm.nih.gov/pubmed/36844734
http://dx.doi.org/10.3389/fcvm.2023.1021959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951003/
https://www.ncbi.nlm.nih.gov/pubmed/36844734
http://dx.doi.org/10.3389/fcvm.2023.1021959

Ejemplares similares